9-substituted minocycline compounds
US6846939B2 · kind B2 · utility
82Cited by
15References
34Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 29, 2001 |
| Grant date | Jan 25, 2005 |
| Priority date | — |
| Expiry date | Jun 29, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.